Health Innovation
In the area of Health Innovation, several research groups at PSI are engaged in the study of fundamental questions regarding biology and cancer therapy. For example, they explore the structure of proteins – extremely complex biomolecules that are responsible for many different functions in organisms. Using PSI’s large research facilities, scientists also explore processes in biological tissue in order to fully understand their function and the development of specific diseases or deterioration processes. The ultimate goal is to find medicines that allow people to live as healthy a life as possible.
Patients with specific types of cancer are treated at the proton therapy facility on the PSI campus. Radiopharmaceuticals provide cancer treatments for very small tumours distributed throughout the body.
Find out more at: Overview Health Innovation
Attacking the lifeline of tumour cells
Researchers at Biomedicum Helsinki, Finland, and the Paul Scherrer Institute (PSI) in Villigen, Switzerland, have determined the crystal structure of the ligand-binding domain of a vascular endothelial growth factor (VEGF) receptor in complex with one of its ligands (VEGF-C).
Ticket für die Reise durch die Zelle
Publikation in Cell. Forscher entdecken Mechanismus für wesentliche Erkennungsvorgänge in lebenden Zellen. Über ihre Ergebnisse berichten die Forscher in der neuesten Ausgabe der Fachzeitschrift Cell.This news release is only available in German.
Komplexe in den Griff bekommen
Die meisten Vorgänge in lebenden Zellen werden von molekularen Maschinen aus vielen Proteinen ausgeführt. Wissenschaftler von PSI und EMBL haben ein automatisiertes Verfahren zur Herstellung von solchen Multiprotein-Komplexen für die Forschung entwickelt.This news release is only available in German.
Röntgenbilder mit Durchblick
Der Nationale Latsis-Preis 2008 geht an Franz Pfeiffer. Der Physiker hat einen Weg gefunden, die in der Spitzenforschung angewandten Verfahren der Röntgentechnik auch für gewöhnliche Röntgengeräte nutzbar zu machen. Der mit 100'000 Franken dotierte Preis wird jährlich vom Schweizerischen Nationalfonds (SNF) im Auftrag der Latsis-Stiftung vergeben.This news release is only available in German.
Promising targets for drug development
ETH Researchers determine atomic structure of the mammalian fatty acid factory. Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is a promising target for the development of anti-cancer and anti-obesity drugs and for the treatment of metabolic disorders. Researchers of ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase.
Vitamin B12 ist das Trojanische Pferd der Krebsforscher am schweizerischen Zentrum für radiopharmazeutische Wissenschaft
Erste Klinische Studie soll Mitte Juni beginnen.This news release is only available in German.
Scharfe Röntgenbilder im Krankenhaus und am Flughafen
Publication in Nature. Researchers at the Paul Scherrer Institute (PSI) and the EPFL in Switzerland have developed a novel method for producing dark-field X-ray images at wavelengths used in typical medical and industrial imaging equipment. Dark-field images provide more detail than ordinary X-ray radiographs and could be used to diagnose the onset of osteoporosis, breast cancer or Alzheimer's disease, to identify explosives in hand luggage, or to pinpoint hairline cracks or corrosion in functional structures.